![Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety](https://pub.mdpi-res.com/cancers/cancers-12-00744/article_deploy/html/images/cancers-12-00744-g001-550.jpg?1585802265)
Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety
![hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer | Journal of Medicinal Chemistry hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer | Journal of Medicinal Chemistry](https://pubs.acs.org/cms/10.1021/acs.jmedchem.3c01210/asset/images/medium/jm3c01210_0008.gif)
hIMB1636-MMAE, a Novel TROP2-Targeting Antibody-Drug Conjugate Exerting Potent Antitumor Efficacy in Pancreatic Cancer | Journal of Medicinal Chemistry
![Monomethyl auristatin E (MMAE, vedotin), la charge utile de cytotoxiques brentuximab vedotin anticorps conjugué Photo Stock - Alamy Monomethyl auristatin E (MMAE, vedotin), la charge utile de cytotoxiques brentuximab vedotin anticorps conjugué Photo Stock - Alamy](https://c8.alamy.com/compfr/dc825k/monomethyl-auristatin-e-mmae-vedotin-la-charge-utile-de-cytotoxiques-brentuximab-vedotin-anticorps-conjugue-dc825k.jpg)
Monomethyl auristatin E (MMAE, vedotin), la charge utile de cytotoxiques brentuximab vedotin anticorps conjugué Photo Stock - Alamy
![IJMS | Free Full-Text | Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody–Drug Conjugates IJMS | Free Full-Text | Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody–Drug Conjugates](https://www.mdpi.com/ijms/ijms-24-11011/article_deploy/html/images/ijms-24-11011-g001.png)
IJMS | Free Full-Text | Tumor Site-Specific Cleavage Improves the Antitumor Efficacy of Antibody–Drug Conjugates
![A first-in-human antibody–drug conjugate: Hope for patients with advanced solid tumours? | Immunopaedia A first-in-human antibody–drug conjugate: Hope for patients with advanced solid tumours? | Immunopaedia](https://www.immunopaedia.org.za/wp-content/uploads/2019/04/020419.jpg)
A first-in-human antibody–drug conjugate: Hope for patients with advanced solid tumours? | Immunopaedia
![Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice | Pharmaceutical Research Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice | Pharmaceutical Research](https://media.springernature.com/m685/springer-static/image/art%3A10.1007%2Fs11095-021-03162-1/MediaObjects/11095_2021_3162_Fig3b_HTML.png)
Development of a Physiologically-Based Pharmacokinetic Model for Whole-Body Disposition of MMAE Containing Antibody-Drug Conjugate in Mice | Pharmaceutical Research
![PDF] Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload | Semantic Scholar PDF] Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7c49c2cf364442a61fe35e998eeb8f932c747af0/2-Figure1-1.png)
PDF] Development and Properties of Valine-Alanine based Antibody-Drug Conjugates with Monomethyl Auristatin E as the Potent Payload | Semantic Scholar
![Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy | Nature Communications Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-022-31601-z/MediaObjects/41467_2022_31601_Fig1_HTML.png)
Monomethyl auristatin antibody and peptide drug conjugates for trimodal cancer chemo-radio-immunotherapy | Nature Communications
![Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. - Abstract - Europe PMC Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. - Abstract - Europe PMC](https://europepmc.org/articles/PMC6927763/bin/kmab-12-01-1699768-g001.jpg)
Clinical pharmacology of vc-MMAE antibody-drug conjugates in cancer patients: learning from eight first-in-human Phase 1 studies. - Abstract - Europe PMC
![Development of MMAE-trastuzumab ADCs. MC-VC-PAB-MMAE was conjugated to... | Download Scientific Diagram Development of MMAE-trastuzumab ADCs. MC-VC-PAB-MMAE was conjugated to... | Download Scientific Diagram](https://www.researchgate.net/publication/344139562/figure/fig1/AS:945197391310850@1602364027854/Development-of-MMAE-trastuzumab-ADCs-MC-VC-PAB-MMAE-was-conjugated-to-trastuzumab.png)
Development of MMAE-trastuzumab ADCs. MC-VC-PAB-MMAE was conjugated to... | Download Scientific Diagram
![Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety](https://www.mdpi.com/cancers/cancers-12-00744/article_deploy/html/images/cancers-12-00744-g001.png)
Cancers | Free Full-Text | Antibody-Drug Conjugate Using Ionized Cys-Linker- MMAE as the Potent Payload Shows Optimal Therapeutic Safety
![Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance | Nature Communications Antibody-drug conjugates with dual payloads for combating breast tumor heterogeneity and drug resistance | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-23793-7/MediaObjects/41467_2021_23793_Fig1_HTML.png)